CVC Nears Deal for Teva's European Women's Health Assets - (Bloomberg via NewsPoints Desk)

  • According to sources, buyout firm CVC Capital Partners is close to an agreement to purchase Teva's European women's health business, Bloomberg reported Wednesday.

  • The people noted that a deal could be reached in the coming days, with the assets expected to fetch as much as $800 million.

  • The sources cautioned that no final decision has been made, while other suitors such as Spain's Chemo Group have expressed interest.

  • Teva, which selected Lundbeck CEO Kaare Schultz as its next chief executive, is seeking to divest non-core assets in an effort to reduce debt.

  • The Israeli firm recently agreed to divest its ParaGard contraceptive business to Cooper Cos. for $1.1 billion.

  • Teva is separately weighing a sale of its European oncology and pain assets.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.